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httpcense.Abstract Introduction: Adaptive support ventilation (ASV) is an improved closed-loop ventila-
tion mode that provides both pressure-controlled ventilation and PSV according to the patient’s
needs.
Aim of the work: To compare the short-term effects of Adaptive support ventilation (ASV), with
conventional Pressure support ventilation (PSV) in weaning of intubated COPD patients.
Patients and methods: Fifty patients admitted in the intensive care with acute exacerbation of
COPD and needing intubation were included in the study. All patients were initially ventilated with
control/assist control mode, in a stepwise manner and were receiving standard medical therapy.
Patients were randomized into two groups to receive either ASV or PSV.
Results: Out of ﬁfty patients included in the study forty one patients in both studied groups were
weaned successfully according to their ABG data and weaning indices. APACHE II score showed
no signiﬁcant difference in both groups. There were statistically signiﬁcant differences between the
groups in term of, duration of mechanical ventilation, weaning hours and length of ICU stay being
shorter in (group 1) weaned by ASV. Re-intubation and mortality rate were higher in (group 11)
weaned by conventional PSV, however the differences were not signiﬁcant.
Conclusion: ASV can provide automated weaning and achieve shorter weaning time for COPD
patients hence leading to reduction in the total duration of MV, length of stay, and hospital costs.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.3156505.
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Chronic obstructive pulmonary disease (COPD) is a disease
with an increasing prevalence and mortality worldwide [1].
The prevalence of COPD is increasing. Recent estimates sug-
gest that there are approximately 23.6 million men and women
with COPD in the U.S. and more than 52 million sufferers
around the world [2].is. Production and hosting by Elsevier B.V.
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450 K.A.E. Mohamed, S.kamal El MaraghiAcute respiratory failure (ARF) due to COPD is becoming
an ever-larger medical and economic problem not only in
developed, but also in developing countries [3].
There is no evidence to prefer a given ventilatory mode to
provide stable support. Assisted modes are used to controlled
modes because in addition to unloading of fatigued muscles,
they allow some patient control over the ventilatory pattern
and reduce disuse atrophy [4]. Patients with acute exacerba-
tions of chronic obstructive pulmonary disease (COPD) often
require either non invasive mechanical ventilation (NIMV) or
invasive mechanical ventilation (IMV) and prolonged weaning
times [5,6]. Although rapid weaning is preferable, there is still
debate on the best weaning procedure. Pressure support venti-
lation (PSV) is a common method of weaning, but it requires
close patient observation for indicators of possible failure [7].
Moreover, intensive care unit (ICU) staff experiencewith PSV
is necessary to set the appropriate level of pressure [8,9]. The last
decadehas seen extensive research being done in the areaofwean-
ing from mechanical ventilation with well designed randomized
controlled trials [10,11]. This has given clinicians data to support
effective decision making in weaning. In the recent years several
ventilatory support modes have been developed in an attempt
to automatically wean patients by feedback from one or more
ventilator measured parameters [12]. Volume support, adaptive
support ventilation and a knowledge based system for adjusting
pressure support have been tried in selected population [13,14].
Adaptive support ventilation (ASV) is an improved closed-loop
ventilation mode that provides both pressure-controlled ventila-
tion and PSV according to the patient’s needs [15,16].
While there have been descriptions of modes for weaning,
including intermittent mandatory ventilation (IMV) and pres-
sure support ventilation (PSV), to date no one method has
been shown to have a clear advantage [17–19].
Aim of the work
To compare the short-term effects of adaptive support ventila-
tion (ASV), an advanced closed-loop mode, with conventional
pressure support ventilation (PSV) in weaning of intubated
COPD patients.
Patients and methods
We collected data over a period of 22 months (June 2010 to
April 2012) in general intensive care unit that contains 22 beds
in Riyadh care hospital, Saudi arabia where this study was car-
ried out. The study was approved by local ethics committee
and a written informed consent was obtained from the patient
and/or next of kin. Fifty COPD patients, admitted to ICU due
to acute exacerbation of their illness and needing intubation
were included in this study. A two group, prospective random-
ized controlled study was carried out. Acute hypercapnic respi-
ratory failure in COPD was deﬁned according to Global
Initiative for Chronic Obstructive Lung Disease GOLD 2007
[20] as severe dyspnoea in the absence of objectively docu-
mented causes such as pneumonia, and with arterial blood
gas analysis (ABG) ﬁndings of:
 pH <7.33 (breathing at room air).
 PaO2 <50 mmHg.
 PaCO2 >50 mmHg.Intubation was done objectively due to respiratory arrest,
loss of consciousness, psychomotor agitation requiring seda-
tion and hemodynamic instability or accumulation of secre-
tions. Patients who had concomitant neurological disease
(other than hypercapnic encephalopathy), cardiac arrest, pul-
monary oedema, heart failure, acute myocardial infarction,
surgical abdominal problem, postoperative respiratory failure
and patients found with high category APACHE-II score
(more than 30) were excluded from the study. Intubation
was done through the orotracheal route with an endotracheal
tube of 8 mm internal diameter or more to minimize the nega-
tive effect of tube resistance. The decision to initiate invasive
ventilatory support was taken by the treating physician if the
response to conservative medical treatment was poor as evi-
denced by the deterioration of arterial blood gas levels as well
as clinical signs. All patients were initially ventilated with con-
trol/assist control mode, in a stepwise manner and were receiv-
ing standard medical therapy with nebulized bronchodilators
corticosteroids and antibiotics if needed. Sedation was
achieved with midazolam and/or fentanyl. Muscle relaxants
and sedation were used as required. Standard ventilator set-
tings for COPD i.e., respiratory rate of 12/min., tidal volume
8–10 mL/kg, FiO2 to obtain a saturation of 90% with a PEEP
of 5 cm H2O and an I:E ratio of 1:2.5–3.0 was initiated. On
admission to ICU full medical history from the patient (if pos-
sible) or his/her relatives, full clinical examination, plain chest
X-ray and ECHO heart, arterial blood gas analysis, serum
electrolytes (Na, K, Cl, Mg, Ca), haematocrit and serum albu-
min were carried out for all patients. Assessment of Glasgow
coma scale (GCS) and Acute Physiology and Chronic Health
Evaluation (APACHE) score. When the patients have reached
satisfactory neurological status, clinical and biochemical
parameters with improvement or resolution of the underlying
cause of acute respiratory failure. In addition, if the patients
showed good tolerance with an acceptable ABG analysis (pH
>7.35, SaO2 of 88% or more for FiO2 of 40% or less) after
a minimum of 24 hours of ventilation and other criteria
according to Raoof (2003) [21]. Patients were randomized
equally into two groups to receive either adaptive support ven-
tilation (group I) or with pressure support ventilation (group
II). Weaning and extubation were performed by the pulmon-
ary and critical care physicians who were not aware of the
study. The initial level of pressure support (above PEEP)
was set at 15 cm H2O in the PSV group. The pressure support
level was then evaluated at least every 30 min and titrated to
keep the respiratory rate at less than 35 breaths/min and, if
possible, gradually decreased to 7 cm H2O by 2 cm H2O. In
our study, minute volume was decreased to 30% in the ASV
mode to achieve lower pressure support levels, as in the PSV
group, and to prepare the patient for extubation. They were
ventilated with the above ﬁnal settings for 2 h and then extu-
bated. Otherwise, the trial was stopped and patients were ven-
tilated with assisted volume controlled ventilation mode and
considered as weaning failure. On the other hand post-extuba-
tion failure occurring within the ﬁrst 48 h was deﬁned as pH
less than 7.35, an increase in arterial carbon dioxide tension
more than 15 mmHg from extubation value, respiratory rate
(RR) more than 24 breaths/min with accessory muscle use
[21]. Tidal volume, PaO2/PAO2, respiratory rate, occlusion
pressure (P0.1), maximal inspiratory pressure (MIP) and
ABG measurements were recorded. Only the values from the
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averaged and analysed. The primary outcome variable was dis-
continuation from mechanical ventilation, which was deﬁned
as independence from ventilatory support >48 hours follow-
ing extubation.
Statistical analysis
All collected Data (i.e., age, BUN, creatinine, arterial blood
gas values, APACHE II scores, and length of ICU stay) were
statistically analysed in terms of mean and standard deviation
(SD) for normal distribution,. We used the student t-test to
compare groups if the values were well distributed, and if
not the Mann–Whitney–U test was performed. To compare
data of categorical variables (i.e., gender, Re-intubation), the
chi-square test was used. P-values less than 0.05 were regarded
as a sign of statistical signiﬁcance. All data analyses were per-
formed using the 16th version of SPSS.Results
During the study period, a total of 2115 patients admitted to
ICU, out of those patients 102 (4.8%) COPD admitted by
acute exacerbation of their illness were needed ICU admis-
sion. 64 patients were treated ﬁrst by non invasive ventilation
and 44 responded after exclusion of 8 patients due to causes
mentioned previously in the methods. A total of 50 intubated
COPD patients were included in the study after an episode of
acute respiratory failure. Table 1 shows the demographic data
and characteristics of the both groups included in the study.
The mean age of the patients was 63.5 ± 9.4 in group 1 and
66.9 ± 7.8 years in group 11. Most of the patients were be-
low 70 kg and the male gender represented by 68% in (group
1) vesus 76% in (group 11). There were no statistically signif-
icant differences in these variables between both groups. The
differences in smoking indices, hypertension, diabetes, in both
studied groups were not signiﬁcant. Also the differences of
other clinical variables such as patients having ischaemicTable 1 Demographic data and patient characteristics of both grou
Group 1
Age in years 63.5 ± 9.4
Gender & (%) 17#:8$ (68:32%)
Weight in kg 57.8 ± 4.9
Hypertension 14 (56%)
Diabe`tes 9 (36%)
Smoking indices 23.6 ± 3.14
APACHE 11score 14 .4 ± 3.9
History of I.H.D 3 (12%)
Renal impairment 1 (4%)
Use of NIV before 9 (36%)
LOS in ICU 7.3 ± 2.6
Duration of MV 113 ± 22.1
Weaning hours 27.3 ± 12.3
Weaning failure 4 (16%)
Reintubation (28 days) 3(12%)
Mortality(28 days) 1(4%)
APACHE 11: Acute Physiology and Chronic Health Evaluation, LOS
ventilation.heart disease or presence of renal impairment were not signif-
icant .The APACHE II score was not signiﬁcantly different in
both groups. There were statistically signiﬁcant differences
between the groups in terms of, duration of mechanical ven-
tilation, weaning hours and length of ICU stay being shorter
in (group 1) weaned by ASV. The total re-intubation rate
through the 28 days follow up was higher in group 11
(16% in group 11 versus 12% in group 1), however the dif-
ference was not signiﬁcant. Table 2 shows insigniﬁcant differ-
ence of ABG in both groups before intubation. Although
better values were seen before extubation in the pH, FiO2,
PaCO2 and Oxygen saturation in group 1 using ASV mode,
the difference between both group was not signiﬁcant (Ta-
ble 3). Forty ﬁve patients were extubated successfully after
the weaning period. Those patients in the ASV group and
the PSV group were considered to be wearable according to
their ABG data and weaning indices. Two patients in the
ASV group and three in the PSV group could not tolerate
weaning and underwent tracheostomy, those patients could
not be weaned in the 28 day follow up. It is necessary to
stress that another four patients, two in each group were
re-intubated within the ﬁrst 48 h was considered as failed
weaning. The difference between the studied groups was
insigniﬁcant regarding electrolytes and serum albumin (Ta-
ble 4). The hemodynamic assessment of patients including
temperature, pulse and mean arterial blood pressure was
acceptable for weaning of our patients and the difference
was insigniﬁcant (Table 5). Echocardiographic data of pa-
tients showed no signiﬁcant differences in LA, LVED and
LVES dimensions and EF% (Table 6). Several indices have
been selected in our study as respiratory rate, tidal volume,
maximal inspiratory pressure, occlusion pressure and CROP
index (thoracic compliance, respiratory rate, arterial oxygen-
ation and MIP). The difference between proposed weaning
indices in the current study was not signiﬁcant between both
groups (Table 7). The overall mortality rate in the 28 day fol-
low up was 6% (one patient in group I and two patients in
group II), out of the 50 COPD patients included in the study,
3 non survived after ICU discharge during their hospital stay.ps.
Group 11 P-value
66.9 ± 7.8 0.6
19#:6$ (76:24%) 0.2
54.2 ± 5.4 0.4
16 (64%) 0.48
11 (44%) 0.3
22.42 ± 4.4 0.7
15.2 ± 4.2 0.6
4 (16%) 0.3
2 (8%) 0.1
11(44%) 0.32
11.7 ± 4.2 0.03
159 ± 37.2 0.036
62 ± 14.1 0.02
5 (20%) 0.3
4 (16%) 0.2
2 (8%) 0.12
: length of stay, NIV: non invasive ventilation, MV: mechanical
Table 2 Arterial blood gases of patients before intubation in
both groups.
Group 1 Group 11 P-value
PH 7.23 ± 0.05 7.25 ± 0.06 0.09
FiO2 0.52 ± 0.13 0.54 ± 0.15 0.3 1
PaCO2 mmHg 78.56 ± 11.5 76.42 ± 17.7 0.54
PaO2 mmHg 52.7 ± 16.3 53.70 ± 19.2 0.73
HCO3 41.82 ± 5.9 1 39.21 ± 6.8 0.7
Oxygen saturation % 82.8 ± 11.4 84.5 ± 10.9 0.6
Table 3 Arterial blood gases of patients before weaning in
both groups.
Group 1 Group 11 P-value
pH 7.4 ± 0.07 7.39 ± 0.06 0.6
Pa,CO2 mmHg 58.32 ± 7.5 60.21 ± 6.7 0.52
FiO2 0.35 ± 0.13 0.37±.15 0.21
PaO2 mmHg 60.7 ± 16.3 57.4 ± 23.2 0.4
HCO3 mmol/L
1 35.3 ± 3.6 36.5 ± 4.1 0.6
Oxygen saturation % 93.8 ± 5.4 90.5 ± 7.9 0.08
Table 4 Laboratory ﬁndings of both groups.
Group 1 Group 11 P-value
Na (mEq/L) 134.6 ± 4.6 134 ± 3.9 0.8
K (mEq/L) 3.9 ± 0.68 3.8 ± 0.47 0.7
Cl (mEq/L) 92.3 ± 4.28 98.77 ± 8.4 0.08
Ca (mg/dL) 9.33 ± 0.9 9.39 ± 0.78 0.23
Mg (mg/dL) 2.2 ± 0.34 2.04 ± 0.19 0.3
Ht % 44.6 ± 3.9 44.5 ± 3.9 0.93
Serum albumin (g/dl) 3.2 ± 0.46 3.45 ± 0.56 0.4
Serum creatinine (mg/dl) 1.19 ± 0.98 1.26 ± 0.89 0.18
Ht: haematocrit.
Table 5 Haemodynamic data in both groups.
Group 1 Group 11 P-value
Pulse (beats/min) 108.5 ± 9.2 103.8 ± 9.5 0.3
MBP (mmHg) 96.7 ± 14.9 105.2 ± 15.9 0.5
Temperature 37.7 ± 1.2 37.5 ± 1.6 0.8
MBP: mean arterial blood pressure.
Table 6 Echo ﬁndings in both groups.
Group 1 Group 11 P-value
LA 4.1 ± 0.34 3.97 ± 0.51 0.08
LVED 4.9 ± 0.32 5.1 ± 0.41 0.09
LVES 3.3 ± 0.45 3.4 ± 0.38 0.2
EF 58.9 ± 2.6 59.1 ± 3.1 0.6
PAP 39.6 ± 7.8 38.7 ± 9.9 0.4
LA: left atrial diameter, LVED: left ventricular end-diastolic
diameter, LVES: left ventricular end-systolic diameter, EF: ejection
fraction, PAP: pulmonary artery pressure.
Table 7 Weaning indices in both studied groups.
Group 1 Group 11 P-value
RR breaths. min 24.3 ± 5.2 23.9 ± 6.3 0.6
VT L 0.393 ± 0.76 0.408 ± 0.46 0.86
Pa,O2/PA,O2 31.8 ± 7.8 32.6 ± 6..9 0.9
MIP cm H2O 41.2 ± 14..3 38.3 ± 11..3 0.45
P0.1 cm H2O 3.3 ± 1.7 3.5 ± 1.5 0.09
CROP mL breath1 min 23.2 ± 7.9 26.1 ± 9.3 0.2
RR: respiratory rate, VT: tidal volume, MIP: maximal inspiratory
pressure (P0.1) occlusion pressure, CROP: compliance, rate, oxy-
genation, pressure index.
452 K.A.E. Mohamed, S.kamal El MaraghiDiscussion
Weaning from mechanical ventilation is essential in the care of
critically ill intubated patients receiving mechanical ventila-
tion. Weaning covers the entire process of liberating the pa-
tient from mechanical support and from the endotracheal
tube [22]. There is uncertainty about the best methods for con-
ducting this process, which will generally require the coopera-
tion of the patient during the phase of recovery from critical
illness [17–19]. This makes weaning an important clinical issue
for patients and clinicians. Despite the increasing use of non-
invasive MV to COPD patients, still 26–74% of them need
invasive mechanical ventilation support [23].
Adaptive support ventilation (ASV); a closed-loop ventila-
tion mode that can act both as pressure support ventilation
(PSV) and pressure-controlled ventilation can be used for
weaning purposes in both acute and chronic respiratory failure
[10]. Weaning with ASV shows promising results, mainly in
post-cardiac surgery patients [13]. The aim of the present ran-
domized controlled study was therefore designed to compare
ASV with PSV in the weaning of COPD patients. In the cur-
rent study the ASV and PSV groups were demographically
comparable at the time of randomization. Factors that could
affect weaning, such as respiratory parameters and severity
of patients illness assessed by APACHE II score were studied
in each group. The main ﬁnding of this study was that, the
weaning process of COPD patients by ASV was associated
with a shorter weaning duration. This was in concordance with
Linton et al., who conducted weaning trials using the ASV
mode and demonstrated the economy of automated weaning
without the need for respiratory therapists or continuous
attendance by intensivists or respiratory therapist [24]. Our
ﬁnding was also supported by Sulzer et al., who reported a
preference for using the ASV mode for postoperative care
[13]. The shorter weaning times with ASV in our study might
be due to the automation of inspiratory pressure levels and re-
duced manipulation and time spent adjusting the ventilator
(manually in PSV versus automatic in ASV). In our study; pa-
tients weaned by using ASV mode showed signiﬁcant short
duration of mechanical ventilation and as weaning accounts
for over 40% of the total MV time [25], hence the total dura-
tion of mechanical ventilated in group I receiving ASV mode
was signiﬁcantly shorter. Our results were supported by Kira-
kli et al., 2011 who rely this to many advantages of ASV mode.
First, it keeps normal ventilation and promotes the ventilatory
pattern associated with the best energetic. Second, taking
into account spontaneous breathing, it is useful to prevent
Role of adaptive support ventilation in weaning of COPD patients 453tachypnea as well as the development of auto-PEEP and exces-
sive dead space ventilation [26]. Weaning decisions based only
on expert clinical judgment are not always correct. On review-
ing the evidence base for ventilator weaning, none of the pre-
dictors of weaning demonstrate more than modest accuracy in
predicting the weaning outcome [25]. To be able to adequately
analyse the data, we ﬁrst had to standardize the weaning pro-
cedures, factors that may affect weaning process as the hemo-
dynamics and serum electrolytes that were statistically
insigniﬁcant between both studied groups. Also echocardiog-
raphy has an important role in examining various cardiac
changes in COPD patients and compare ejection fraction in
both groups, a factor that may affect weaning .Our current
study showed, no signiﬁcant difference was observed between
the two groups on comparing the mean ± SD of LV internal
dimensions and ejection fraction. In the McMaster review
and guidelines 66 predictors of weaning were reviewed and
analysed. Only eight presented signiﬁcant likelihood ratios to
predict the weaning outcome [27]. The threshold values of dif-
ferent weaning indices and measured respiratory parameters
obtained in our COPD patients could differ from those men-
tioned by Esteban et al., who reported weaning success rates
of 70% for PSV but their study was performed on a heteroge-
neous population, and only 20% of the patients enrolled had
COPD [7]. Our parameters of weaning indices in both groups
were comparable with that found by Alvisi et al. [28]. A ﬁnding
that helps the comparison to be fair in our study was that the
mean values for all these parameters of weaning indices in both
groups were found to be in the appropriate range for successful
weaning and there was no signiﬁcant difference between ASV
and PSV when these data were compared. It is important to
emphasis that both ASV and PSV are suitable methods for
successful weaning of patients with COPD from MV, although
ASV proved to be more successful according to the measured
parameters in the current study. Brochard et al. compared syn-
chronized intermittent mandatory ventilation, PSV, and T-
tube weaning method, and found that PSV was superior to
the other two methods of weaning from mechanical ventila-
tion. Their ﬁnding of PSV group was different to our results,
as we have to take into account the differences in the inclusion
criteria [29]. Several indices have been proposed in our study as
respiratory rate, tidal volume, maximal inspiratory pressure,
occlusion pressure and CROP index (thoracic compliance,
respiratory rate, arterial oxygenation and MIP. Our results
show that these indices may be useful as these were compara-
ble to that reported by MacIntyre in predicting weaning suc-
cess or failure in ventilated COPD patients in a phase of
clinical stability [25]. The success rate of weaning obtained in
our COPD patients was more than 80% which could be higher
than that reported by Esteban et al., for patients weaned by
PSV [7] .This difference could be related to a heterogeneous
population in the former study as mentioned before beside
longer period of ventilation. On the other hand, Moc¸in et al.
studied COPD patients, the weaning success rates was 42.4%
in the ﬁrst weaning trial [30]. This lower rate could be related
to co-morbid diseases especially heart and renal diseases as
well as the longer duration of mechanical ventilation.
Scho¨nhofer et al., also conﬁrmed that a longer duration of
mechanical ventilation is an important risk factor for weaning
failure, morbidity and mortality [10].
Although weaning success rates was higher in ASV group,
it was statistically insigniﬁcant between both group. This couldbe explained by the demographic variables of the patients as
well as the parameters that affect weaning process were com-
parable in both studied group. In addition the evaluation of
the weaning indices aids in identifying the causative factor of
MV weaning failure, which can then be treated. Death during
hospitalization, in fact, was low in our study as this could be
explained by the selection of patients and exclusion criteria
especially those with high category APACHE-II score. This
was probably one of the reasons why there was no signiﬁcant
difference between groups in mortality. The cause of death
could not be considered in our analysis, since information ob-
tained by telephone was not always sufﬁciently precise in addi-
tion to lack of collaboration (after ICU discharge).
Limitations
We acknowledge that the study has some limitations. First;
our study population represents a highly selective population
of COPD patients admitted for mechanical ventilation. The
potential of selection biases the population under investiga-
tion. Second; there were confounding variables as the treating
physicians, hospital discharge, and in-puts from the patient’s
families. We controlled such factors by strictly following the
policy of ICU discharge besides that the treating physicians
were not aware about the study.
Conclusion
According to our results; there appear to be several advan-
tages for using the ASV. First, the ASV can provide auto-
mated weaning and achieves shorter weaning time for
COPD patients. Second, the economy of automated weaning
lessens the need for continuous attendance at bedside by
intensivists and respiratory therapists to make sure the ven-
tilator is meeting the patient’s needs. Lastly; ASV provides
reduction in the total duration of MV, length of stay, and
hospital costs.
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